- Improved data quality through electronic requisitions and simplified medical reporting resolutions
- Improved sample tracking and traceability through electronic sample tracking
- Improved data consistency and fewer queries through the availability of online Standard Operating Procedures (SOPs) and training
- Reduced query resolution time through email alerts for unviewed medical reports or unanswered queries
According to Michelle Kopfinger, an investigator site coordinator, “Quintiles is making proactive changes to help make lab management from a site perspective less burdensome. All of the lab reports are at the tip of your fingers and the data clarifications are resolved quicker through the system. It’s a great tool for managing lab reports.”This announcement comes on the heels of Quintiles receiving the 2013 Informatica Innovation Award for “Enterprise Data Integration” for Infosario’s pioneering efforts to integrate clinical research and healthcare data across numerous institutions and at a scale never before accomplished in the biopharmaceutical industry. For more information, view the Infosario portal fact sheet and website. Demonstrations of Infosario will be available at the Drug Information Association (DIA) Annual Meeting on June 24-27 in Boston, Mass. About Quintiles Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. Click here to subscribe to Mobile Alerts for Quintiles.